Cigna Corp (NY:CI)

Humana has notably underperformed the S&P 500 over the past year, but analysts are moderately optimistic about the stock’s prospects.

Is Humana Stock Underperforming the S&P 500?

March 09, 2026

THE CIGNA GROUP (NYSE:CI) Shows High Technical and Setup Ratings Ahead of Potential Breakout ↗

Topics Stocks

February 17, 2026

Via Chartmill

Health Insurance Providers Stocks Q4 Recap: Benchmarking Cigna (NYSE:CI)

March 08, 2026

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, i...

Envista, Baxter, Artivion, Dentsply Sirona, and Cigna Stocks Trade Down, What You Need To Know

Topics Artificial Intelligence Economy Fraud

Here's How Much $1000 Invested In Cigna Group 15 Years Ago Would Be Worth Today ↗

March 06, 2026

Via Benzinga

March 06, 2026

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...

Cigna announced earlier on Tuesday that David M. Cordani will retire as CEO effective July 1, 2026, to be succeeded by Brian Evanko.

Topics Economy

Cigna Group Announces New CEO; Wall Street Admits Surprise But Remains Bullish ↗

March 03, 2026

Via Stocktwits

Topics Retirement

Cigna Stock Falls After CEO Retirement Announcement ↗

March 03, 2026

The Cigna Group (NYSE:CI) shares are trading lower Tuesday after the company announced that David Cordani will retire as CEO.

Via Benzinga

Topics Retirement

Is Elevance Health Stock Underperforming the Dow?

March 02, 2026

Elevance Health has lagged behind the broader Dow Jones Industrial Average over the past year, and analysts are cautiously bullish about its future prospects.

Over the last six months, Abbott Laboratories’s shares have sunk to $116.31, producing a disappointing 11.5% loss - a stark contrast to the S&P 500’s 7.7% gain. This was partly driven by its softer...

Topics Stocks

2 Reasons to Like ABT and 1 to Stay Skeptical

March 01, 2026

Cigna Group shows mixed price performance, yet sound fundamentals support analyst conviction for continued growth.

Topics Stocks Supply Chain

Is Cigna Group Stock Underperforming the Dow?

February 27, 2026

Pacira (PCRX) Q4 2025 Earnings Call Transcript

Topics Stocks

Pacira (PCRX) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Via The Motley Fool

Topics Earnings Intellectual Property

Here's How Much $100 Invested In Cigna Group 15 Years Ago Would Be Worth Today ↗

February 26, 2026

Via Benzinga

Molina Healthcare (MOH): Buy, Sell, or Hold Post Q4 Earnings?

February 25, 2026

Over the past six months, Molina Healthcare’s shares (currently trading at $145.75) have posted a disappointing 16.6% loss, well below the S&P 500’s 6.5% gain. This was partly due to its softer...

The Great Managed Care Reset: UnitedHealth’s 2025 Profit Slump Signals a New Era of Austerity for Medicare Advantage

Topics Stocks Supply Chain

February 25, 2026

The "golden era" of the managed care sector came to an abrupt and painful halt this year, as UnitedHealth Group (NYSE: UNH) reported a staggering 16% decline in full-year 2025 net profits. This...

Health insurance company Clover Health (NASDAQ:CLOV) will be reporting results tomorrow after market hours. Here’s what to look for.

Topics Earnings Economy

Clover Health (CLOV) To Report Earnings Tomorrow: Here Is What To Expect

February 25, 2026

Health insurance company Alignment Healthcare (NASDAQ:ALHC) will be reporting results this Thursday after market hours. Here’s what investors should know.

Topics Artificial Intelligence

Alignment Healthcare (ALHC) Reports Q4: Everything You Need To Know Ahead Of Earnings

February 24, 2026

Fertility benefits company Progyny (NASDAQ:PGNY) will be reporting earnings this Thursday after market close. Here’s what to look for.

Topics Artificial Intelligence Government World Trade

Progyny (PGNY) Q4 Earnings Report Preview: What To Look For

February 24, 2026

As of late February 2026, the U.S. stock market has reached a definitive turning point that many analysts have predicted for years: the era of "narrow leadership" is officially ending. While the S&P...

Topics Artificial Intelligence World Trade

The Great Convergence: How the 'S&P 493' is Finally Stealing the Spotlight from Big Tech

February 24, 2026

As of February 20, 2026, UnitedHealth Group (NYSE: UNH) finds itself at a historic crossroads. For decades, the Minnetonka-based behemoth was the undisputed gold standard of the healthcare sector—a...

Topics Artificial Intelligence Economy Stocks

The Resilience of a Healthcare Titan: A Deep Dive into UnitedHealth Group (UNH) in 2026

February 20, 2026

Via Finterra

Topics Artificial Intelligence Retirement Stocks

Health Care Sector (XLV) Shows Resilience Amid Tech Volatility and Strong Jobs Data

February 18, 2026

As the broader market grappled with a violent valuation reset in the technology sector, the health care industry emerged as a critical anchor for investors in early 2026. The Health Care Select Sector...

Cigna’s fourth quarter results were well received by the market, reflecting the company’s ability to navigate industry disruptions and deliver on key growth priorities. Management credited the...

Topics Artificial Intelligence ETFs Earnings

Here's How Much $1000 Invested In Cigna Group 15 Years Ago Would Be Worth Today ↗

February 17, 2026

Via Benzinga

5 Revealing Analyst Questions From Cigna’s Q4 Earnings Call

February 12, 2026

As of February 11, 2026, Humana Inc. (NYSE: HUM) finds itself at a historic crossroads. Once the darling of the managed care sector, the Louisville-based insurer is currently navigating a "perfect...

Topics Earnings

Humana at the Crossroads: A Deep-Dive into the 2026 Operational Reset

February 11, 2026

Via Finterra

Topics Economy

1 Safe-and-Steady Stock with Exciting Potential and 2 We Brush Off

February 10, 2026

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

CVS Health Navigates a Stormy 2026: Record Revenue Tempered by Medicare Advantage Costs and PBM Turmoil

February 10, 2026

In a pivotal earnings report delivered on February 10, 2026, CVS Health (NYSE: CVS) showcased a complex narrative of financial resilience and operational headwinds. While the healthcare giant posted...

Health insurance company Humana (NYSE:HUM) will be reporting results this Wednesday before market hours. Here’s what to look for.

Topics Economy

Humana (HUM) Q4 Earnings: What To Expect

February 09, 2026

Landmark Settlement: The Cigna Group Resolves FTC Insulin Pricing Suit, Reshaping the PBM Landscape

Topics Artificial Intelligence World Trade

February 09, 2026

In a move that marks a definitive shift in the American pharmaceutical supply chain, The Cigna Group (NYSE: CI) has reached a comprehensive settlement with the Federal Trade Commission (FTC) to resolve...

Cigna has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

Topics Economy Lawsuit

Cigna Stock: Is Wall Street Bullish or Bearish?

February 09, 2026